CSPC Innovation Pharmaceutical Co Ltd Class A Capital Reinvestment Ratio
CSPC Innovation Pharmaceutical Co Ltd Class A capital reinvestment ratio. CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has a Capital Reinvestment Ratio of 5.62x as of June 2024, meaning it reinvests 6% of its operating cash flow (CN¥33.92 Million) in capital expenditures (CN¥190.69 Million). Check 300765 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2023)
Capital reinvestment ratio of CSPC Innovation Pharmaceutical Co Ltd Class A from 2014 to 2023. This chart tracks CSPC Innovation Pharmaceutical Co Ltd Class A's Capital Reinvestment Ratio across 10 annual periods. Also explore 300765 net asset momentum to track the company's year-over-year net asset growth rate.
CSPC Innovation Pharmaceutical Co Ltd Class A Capital Reinvestment Ratio by Year (2014–2023)
CSPC Innovation Pharmaceutical Co Ltd Class A capital reinvestment ratio by year from 2014 to 2023. For the full cash flow conversion analysis, see 300765 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.10x | CN¥927.24 Million | CN¥95.73 Million | ▼ -42.0% |
| 2022 | 0.18x | CN¥640.72 Million | CN¥114.05 Million | ▼ -22.3% |
| 2021 | 0.23x | CN¥292.09 Million | CN¥66.92 Million | ▼ -32.1% |
| 2020 | 0.34x | CN¥349.07 Million | CN¥117.74 Million | ▲ +0.3% |
| 2019 | 0.34x | CN¥315.38 Million | CN¥106.10 Million | ▼ -8.9% |
| 2018 | 0.37x | CN¥159.73 Million | CN¥58.96 Million | ▼ -98.9% |
| 2017 | 32.90x | CN¥1.30 Million | CN¥42.78 Million | ▲ +2956.1% |
| 2016 | 1.08x | CN¥137.27 Million | CN¥147.79 Million | ▲ +153.1% |
| 2015 | 0.43x | CN¥112.05 Million | CN¥47.67 Million | ▲ +391.3% |
| 2014 | 0.09x | CN¥93.36 Million | CN¥8.09 Million | — |